Hexter Joshua
SEC insider (Form 3/4/5 filer). CIK 0001573235. COO & CBO at ORAMED PHARMACEUTICALS INC. (ORMP) and 1 other issuer. 17 reported Form 4/5 transactions since Sep 2024; latest on Oct 1, 2026. Located in NEW YORK, NY.
Companies Hexter Joshua has filed insider reports for
- ORAMED PHARMACEUTICALS INC. (ORMP): Officer, COO & CBO
- Lifeward Ltd. (LFWD)
Hexter Joshua
CIK: 0001573235
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (17 total)
- Oct 1, 2026ORMP
ORAMED PHARMACEUTICALS INC.
SaleDirect30K shares at avg. $4.51$135K - Sep 24, 2026ORMP
ORAMED PHARMACEUTICALS INC.
AwardDirect75.5K shares- - Sep 24, 2026ORMP
ORAMED PHARMACEUTICALS INC.
DispositionDirectStock option (right to buy)
36K shares- - Sep 24, 2026ORMP
ORAMED PHARMACEUTICALS INC.
DispositionDirectStock option (right to buy)
50K shares- - Sep 24, 2026ORMP
ORAMED PHARMACEUTICALS INC.
DispositionDirectStock option (right to buy)
50K shares- - Sep 24, 2026ORMP
ORAMED PHARMACEUTICALS INC.
AwardDirect209.3K shares- - Jul 2, 2026ORMP
ORAMED PHARMACEUTICALS INC.
ExerciseDirect50K shares at avg. $3.69$185K - Jul 1, 2026ORMP
ORAMED PHARMACEUTICALS INC.
SaleDirect137K shares at avg. $4.46$611K - Mar 17, 2026ORMP
ORAMED PHARMACEUTICALS INC.
AwardDirect95.9K shares- - Jan 22, 2026ORMP
ORAMED PHARMACEUTICALS INC.
ExerciseDirect19K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 1, 2026 |  ORMP ORAMED PHARMACEUTICALS INC. | Sale | 30,000 | $4.51 | $135,330 | Direct |
| Sep 24, 2026 | ORMP ORAMED PHARMACEUTICALS INC. | Award | 75,455 | - | $0 | Direct |
| Sep 24, 2026 | ORMP ORAMED PHARMACEUTICALS INC. | Disposition Stock option (right to buy) | 36,000 | - | - | Direct |
| Sep 24, 2026 | ORMP ORAMED PHARMACEUTICALS INC. | Disposition Stock option (right to buy) | 50,000 | - | - | Direct |
| Sep 24, 2026 | ORMP ORAMED PHARMACEUTICALS INC. | Disposition Stock option (right to buy) | 50,000 | - | - | Direct |
| Sep 24, 2026 | ORMP ORAMED PHARMACEUTICALS INC. | Award | 209,291 | - | $0 | Direct |
| Jul 2, 2026 | ORMP ORAMED PHARMACEUTICALS INC. | Exercise | 50,000 | $3.69 | $184,500 | Direct |
| Jul 1, 2026 | ORMP ORAMED PHARMACEUTICALS INC. | Sale | 137,000 | $4.46 | $611,431 | Direct |
| Mar 17, 2026 | ORMP ORAMED PHARMACEUTICALS INC. | Award | 95,889 | - | $0 | Direct |
| Jan 22, 2026 | ORMP ORAMED PHARMACEUTICALS INC. | Exercise | 19,000 | - | $0 | Direct |
1-10 of 17 transactions